Search

TRX1

TRX1 is being developed for the potential treatment of autoimmune diseases in collaboration with Genentech, Inc. TolerRx is currently conducting a Phase I clinical study of TRX1 in the United Kingdom.

Trimethyldiphenylpropylamine

SQ-109

SQ-109 is an orally active, small molecule antibiotic for treatment of pulmonary TB.

IDM-2

IDM-2 is composed of Monocyte-derived Activated Killer (MAK) cells. IDM produces MAK cells from the patient's own white blood cells by activating these cells ex vivo to allow them to recognize and destroy tumor cells.

Dirlotapide

It is marketed by Pfizer and Zoetis under the brand name, _Slentrol_, and is not intended for human use.

tgAAVCF

It is being investigated for the treatment of cystic fibrosis.[A259821, A259826]

Tubercidin

An antibiotic purine ribonucleoside that readily substitutes for adenosine in the biological system, but its incorporation into DNA and RNA has an inhibitory effect on the metabolism of these nucleic acids

Pentaerythritol tetranitrate

Interestingly, this drug was studied for potential benefits in chronic ischemic heart failure patients.

AVR118

of cancers); for its ability to stimulate the immune system to attack tumor cells (especially those cancer cells that have been damaged by chemotherapeutic agents) and for its ability to treat cachexia … AVR118 is being studied for the promise shown in its ability to mitigate the toxic side effects of other drugs (including those used to treat HIV infection and chemotherapeutic drugs employed in the treatment

Flomoxef

Flomoxef has been used in trials studying the treatment of Urinary Tract Infection.